Visceral adipocytes: Old actors in obesity and new protagonists in Crohn's disease?

Gut

Volumn 61, Issue 1, 2012, Pages 86-94

  Zulian, Alessandra ^a   Cancello, Raffaella ^a   Micheletto, Giancarlo ^b   Gentilini, Davide ^a   Gilardini, Luisa ^a   Danelli, Piergiorgio ^c   Invitti, Cecilia ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE; ADIPOSE TISSUE; ADULT; ARTICLE; BODY WEIGHT; CELL FUNCTION; CELL ISOLATION; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNITY; INFLAMMATION; INTESTINE; LIPID METABOLISM; LIPID STORAGE; MALE; MESENTERY; MOLECULAR BIOLOGY; OBESITY; OMENTUM; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SUBCUTANEOUS FAT; TISSUE MICROARRAY; TISSUE STRUCTURE; VISCERA;

ABDOMINAL FAT; ADIPOCYTES; ADIPOSE TISSUE; ADULT; CROHN DISEASE; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; MALE; MESENTERY; MIDDLE AGED; OBESITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 83555176392     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2011-300391     Document Type: Article

References (32)

1. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004;89:2548-56. (Pubitemid 38766330)
2. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010;314:1-16.
3. Ritchie SA, Connell JM. The link between abdominal obesity, metabolic syndrome and cardiovascular disease. Nutr Metab Cardiovasc Dis 2007;17:319-26. (Pubitemid 46551691)
4. Bluher M. The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 2010;21:38-43.
5. Cancello R, Tordjman J, Poitou C, et al. Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity. Diabetes 2006;55:1554-61. (Pubitemid 44324107)
6. Conus F, Rabasa-Lhoret R, Peronnet F. Characteristics of metabolically obese normal-weight (MONW) subjects. Appl Physiol Nutr Metab 2007;32:4-12.
7. Nagahori M, Hyun SB, Totsuka T, et al. Prevalence of metabolic syndrome is comparable between inflammatory bowel disease patients and the general population. J Gastroenterol 2010;45:1008-13.
8. Price AB, Talbot IC, Thompson H, et al. Pathogenesis of Crohn's disease. Lancet 1990;335:858. (Pubitemid 20113767)
9. Crohn BB, Ginzburg L, Oppenheimer GD. Landmark article Oct 15, 1932. Regional ileitis. A pathological and clinical entity. By Burril B. Crohn, Leon Ginzburg, and Gordon D. Oppenheimer. JAMA 1984;251:73-9.
10. Peyrin-Biroulet L, Chamaillard M, Gonzalez F, et al. Mesenteric fat in Crohn's disease: a pathogenetic hallmark or an innocent bystander? Gut 2007;56:577-83. (Pubitemid 46580516)
11. Sheehan AL, Warren BF, Gear MW, et al. Fat-wrapping in Crohn's disease: pathological basis and relevance to surgical practice. Br J Surg 1992;79:955-8.
12. Pond CM. Adipose tissue and the immune system. Prostaglandins Leukot Essent Fatty Acids 2005;73:17-30. (Pubitemid 40826924)
13. Bertin B, Desreumaux P, Dubuquoy L. Obesity, visceral fat and Crohn's disease. Curr Opin Clin Nutr Metab Care 2010;13:574-80.
14. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57.
15. Brazma A. Minimum Information About a Microarray Experiment (MIAME)- successes, failures, challenges. ScientificWorldJournal 2009;9:420-3.
16. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8. (Pubitemid 351818697)
17. Lee YH, Nair S, Rousseau E, et al. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005;48:1776-83. (Pubitemid 41317831)
18. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004;18:1657-69. (Pubitemid 39463705)
19. Barbier M, Vidal H, Desreumaux P, et al. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003;27:987-91. (Pubitemid 37516823)
20. Schaffler A, Furst A, Buchler C, et al. Vascular endothelial growth factor secretion from mesenteric adipose tissue and from creeping fat in Crohn's disease. J Gastroenterol Hepatol 2006;21:1419-23. (Pubitemid 44154710)
21. Schaffler A, Herfarth H. Creeping fat in Crohn's disease: travelling in a creeper lane of research? Gut 2005;54:742-4. (Pubitemid 40732083)
22. Keophiphath M, Achard V, Henegar C, et al. Macrophage-secreted factors promote a profibrotic phenotype in human preadipocytes. Mol Endocrinol 2009;23:11-24.
23. Liu A, Sonmez A, Yee G, et al. Differential adipogenic and inflammatory properties of small adipocytes in Zucker Obese and Lean rats. Diab Vasc Dis Res 2010;7:311-18.
24. Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 2007;117:175-84. (Pubitemid 46048464)
25. Skurk T, Alberti-Huber C, Herder C, et al. Relationship between adipocyte size and adipokine expression and secretion. J Clin Endocrinol Metab 2007;92: 1023-33. (Pubitemid 46465679)
26. Parmentier-Decrucq E, Duhamel A, Ernst O, et al. Effects of infliximab therapy on abdominal fat and metabolic profile in patients with Crohn's disease. Inflamm Bowel Dis 2009;15:1476-84.
27. Hu F, Liu F. Mitochondrial stress: a bridge between mitochondrial dysfunction and metabolic diseases? Cell Signal 2011;23:1528-33.
28. Chen XH, Zhao YP, Xue M, et al. TNF-alpha induces mitochondrial dysfunction in 3T3-L1 adipocytes. Mol Cell Endocrinol 2010;328:63-9.
29. Olivier I, Theodorou V, Valet P, et al. Is Crohn's creeping fat an adipose tissue? Inflamm Bowel Dis 2011;17:747-57.
30. Behr MA, Divangahi M, Lalande JD. What's in a name? The (mis)labelling of Crohn's as an autoimmune disease. Lancet 2010;376:202-3.
31. Peyrin-Biroulet L, Chamaillard M. NOD2 and defensins: translating innate to adaptive immunity in Crohn's disease. J Endotoxin Res 2007;13:135-9. (Pubitemid 47471315)
32. Vachharajani V, Granger DN. Adipose tissue: a motor for the inflammation associated with obesity. IUBMB Life 2009;61:424-30.